Optogenetics Nobel adds millisecond control to a line of brain-tool prizes dating to 1906
Optogenetics, the use of light to control neurons millisecond by millisecond, won its developers the 2026 Nobel Prize in physiology or medicine. A neuroscientist's account places it third, after tools for seeing and measuring the brain, and treats the therapies it may enable as projections.
The Scientist · Science desk
What happened
- Golgi's silver stain, and Cajal's paintings of the neurons it made visible, won the 1906 Nobel, the earliest prize in the account.
- Hodgkin and Huxley won the 1963 Nobel for capturing and measuring the electrical impulses neurons use to communicate.
- The 2003 Nobel went to the fast imaging sequences and spatial encoding behind functional MRI, which tracks blood flow across the whole brain.
- Today's probes record the electrical activity of hundreds of neurons from different brain areas at the same time.
- Studies published in 2025 found 95% of an animal's brain active during a decision, including areas not usually tied to decision-making.
Why it matters
- What doesn't add up contradiction Neuron control predates the optogenetics prize by close to four decades and imaging won again in 2003, so a forecast built on a clean see-measure-control order starts from a sequence whose stages actually overlap.
- What it limits constraint If a decision draws on most of an animal's brain, a therapy that steers one region with light acts on only part of the activity behind the behaviour it aims to change.
- Who has to decide decision Backers of neurotechnology for eyesight, pain or epilepsy are backing what the author calls a 'could be', and the prize for a laboratory tool is no substitute for human data.
Next story · Science · Oct 7
Optogenetic gene therapy improves light sensitivity in 7 of 10 people blinded by retinitis pigmentosaConfirmed2 publishers
The author describes "a rough pattern" [3], and the dates in the account show how rough it is. Imaging won again in 2003, forty years after the prize for measuring neurons' electrical impulses [13]. Control is also older than the technique that won this year. Researchers have been able to control the activity of specific neurons since the late 1980s [10], close to four decades before the 2026 prize [14]. The stages overlap. Light adds timing, so researchers can change what neurons do millisecond by millisecond [1].
Recording has not kept up with that. A single cubic millimetre of tissue, about the size of a poppy seed, holds tens of thousands of neurons and support cells [4]. Today's probes pick up hundreds of neurons spread across several brain areas [8]. Put the two figures together at order of magnitude and a whole recording comes to about one percent of the cells in that one cube [15]. Mapping structure is further along. Expansion microscopy swells tissue with the same gel found in baby diapers. Paired with electron microscopy and AI algorithms, it lets scientists see the complexity inside a cubic millimetre [11].
The 2025 decision studies leave open what the 95% figure is a share of. The account gives it as 95% of the brain, in animals [9], and does not say whether it counts regions, recorded neurons or something else. Nor does it say whether the finding holds in human brains, the ones the proposed therapies would treat [16].
On therapy, the author states the hedge plainly. The piece says "the ability to therapeutically adjust brain activity in ways that previously sounded like fantasy could be on the horizon", and gives restored eyesight, pain relief, epilepsy and mental health disorders as examples [16]. The prize went to the laboratory tool that might one day reach those targets [2].
I think the next step in the sequence is closing the gaps between its stages, because control now runs ahead of recording. I'd expect the advances that matter for treatment to come from tools that record many neurons while controlling a few. That view holds on one condition: the 2025 finding of brain-wide involvement has to survive once its counting method is clear [9].
What to watch
- Published detail on the 2025 decision studies: what the 95% counts, and whether brain-wide involvement appears beyond the animals tested.
- Human data on optogenetic approaches to any of the author's listed targets: eyesight, pain, epilepsy or mental health disorders.
- Recording probes that reach well beyond hundreds of neurons at once, so millisecond control experiments can be read out across more of a circuit.
Clarity's read
What the record supports and how the coverage leans. The claims behind it follow.
Reality
- Evidence62
- Adoption25
- Hype gap+15
- Incentives
- Not scored
- Confidence65
Claim ledger
Ranked by verification strength, evidence, and original report placement.
- [1]
Optogenetics, the use of light to influence neuronal function, allows neuroscientists to manipulate what neurons do millisecond by millisecond.
- [2]
The researchers whose work led to optogenetics won the 2026 Nobel Prize in physiology or medicine.
- [3]
"There is a rough pattern to the technological advances that have led neuroscience to the present day: visualize the brain, measure its function and then control it."
- [4]
A cubic millimeter of brain, about the size of a single poppy seed, contains tens of thousands of neurons and other brain support cells.
- [5]
In the late 1800s Santiago Ramon y Cajal painted neurons seen in brain tissue stained with silver, a technique developed by Camillo Golgi; their work won the 1906 Nobel Prize in physiology or medicine.
- [6]
In 2003 the Nobel Prize in physiology or medicine was awarded for the development of MRI techniques that make functional MRI possible: fast imaging sequences and spatial encoding. Functional MRI measures blood flow across the whole brain noninvasively.
- [7]
Alan Hodgkin and Andrew Huxley won the 1963 Nobel Prize in physiology or medicine for capturing and measuring the electrical impulses that neurons create to communicate.
- [8]
Current probes for measuring neurons' electrical activity can record hundreds of neurons from different brain areas at the same time.
- [9]
A series of studies published in 2025 showed that while an animal is making a decision, 95% of the brain is actively involved, not just neurons in areas typically associated with decision-making.
- [10]
The ability to control the activity of specific neurons has existed since the late 1980s.
- [11]
Expansion microscopy uses the same type of gel found in baby diapers to physically enlarge tissue; with electron microscopy and artificial intelligence algorithms, it lets scientists see the complexity within a cubic millimeter of brain tissue.
- [12]
The brain-tool prizes in the account span 120 years, from 1906 to 2026.
- [13]
The 2003 MRI prize came 40 years after the 1963 prize for measuring neurons' electrical impulses.
- [14]
Control of specific neurons predates the 2026 optogenetics prize by close to four decades.
- [15]
A recording of hundreds of neurons is on the order of one percent of the tens of thousands of cells in a single cubic millimetre of brain.
- [16]
"the ability to therapeutically adjust brain activity in ways that previously sounded like fantasy could be on the horizon", including restoring eyesight, reducing pain and treating diseases like epilepsy and mental health disorders.
Sources
2 independent publishers whose own reporting we read for this story.
Topics and entities
Topics
Entities
- Nobel Prize in Physiology or Medicine
- Deep Brain Stimulation
- Alim-Louis Benabid
- Channelrhodopsin
- Santiago Ramón y Cajal